Despite declining revenues, investors are questionable for k...
Despite declining revenues, investors are questionable for keeping P/S from dropping, likely affecting the share price negatively. The company may be overvalued given the gloomy revenue outlook, suggesting a premium paid for the stock.
Lushang Freda Pharmaceutical Co.,Ltd.'s (SHSE:600223) Shares May Have Run Too Fast Too Soon
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment